0001140361-16-076941.txt : 20160817 0001140361-16-076941.hdr.sgml : 20160817 20160816190740 ACCESSION NUMBER: 0001140361-16-076941 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160817 DATE AS OF CHANGE: 20160816 EFFECTIVENESS DATE: 20160817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tioma Therapeutics, Inc. CENTRAL INDEX KEY: 0001630680 IRS NUMBER: 262012816 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-245292 FILM NUMBER: 161837226 BUSINESS ADDRESS: STREET 1: 4320 FOREST PARK AVE., SUITE 304 CITY: SAINT LOUIS STATE: MO ZIP: 63108 BUSINESS PHONE: 860-938-2315 MAIL ADDRESS: STREET 1: 4320 FOREST PARK AVE., SUITE 304 CITY: SAINT LOUIS STATE: MO ZIP: 63108 FORMER COMPANY: FORMER CONFORMED NAME: Vasculox, Inc. DATE OF NAME CHANGE: 20150113 D/A 1 primary_doc.xml X0707 D/A LIVE 0001630680 Tioma Therapeutics, Inc. 2000 SIERRA POINT PARKWAY, SUITE 700 BRISBANE CA CALIFORNIA 94005 4156714024 DELAWARE None Vasculox, Inc. Corporation true Jill Carroll c/o Tioma Therapeutics, Inc. 2000 SIERRA POINT PARKWAY, SUITE 700 BRISBANE CA CALIFORNIA 94005 Director Robert W. Karr c/o Tioma Therapeutics, Inc. 4320 FOREST PARK AVE., SUITE 304 SAINT LOUIS MO MISSOURI 63108 Executive Officer Pamela T. Manning c/o Tioma Therapeutics, Inc. 4320 FOREST PARK AVE., SUITE 304 SAINT LOUIS MO MISSOURI 63108 Executive Officer John McKearn c/o Tioma Therapeutics, Inc. 2000 SIERRA POINT PARKWAY, SUITE 700 BRISBANE CA CALIFORNIA 94005 Director Peter Moldt c/o Tioma Therapeutics, Inc. 2000 SIERRA POINT PARKWAY, SUITE 700 BRISBANE CA CALIFORNIA 94005 Director John Donovan c/o Tioma Therapeutics, Inc. 2000 SIERRA POINT PARKWAY, SUITE 700 BRISBANE CA CALIFORNIA 94005 Executive Officer Director Carole L. Nuechterlein c/o Tioma Therapeutics, Inc. 2000 SIERRA POINT PARKWAY, SUITE 700 BRISBANE CA CALIFORNIA 94005 Director James Stutz c/o Tioma Therapeutics, Inc. 2000 SIERRA POINT PARKWAY, SUITE 700 BRISBANE CA CALIFORNIA 94005 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001630680-15-000002 2015-06-25 true true true Issuance and sale of shares of Series A Preferred Stock and the underlying shares of Common Stock issuable upon conversion thereof. false 0 86253438 33176948 53076490 false 12 0 0 0 false Tioma Therapeutics, Inc. /s/ James Stutz James Stutz Chief Business Officer 2016-08-16